Klara Dickinson

VP, Regulatory Affairs, COTHERIX INC.

Companies

CymaBay Therapeutics (United States)SVP, Regulatory Affairs & QA Jun 30, 2017 to Mar 22, 2024¹
Anthera PharmaceuticalsSVP & Chief Regulatory Officer Jun 2, 2015 to May 22, 2017²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

CymaBay Therapeutics (United States)0 shares³Mar 22, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 22, 2024Returned to company 21,000 shares of CymaBay Therapeutics (United States)³
Jan 24, 2024Granted 21,000 shares of CymaBay Therapeutics (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCymaBay Therapeutics (United States), SVP, Regulatory Affairs & QA
2
SEC EDGARAnthera Pharmaceuticals, SVP & Chief Regulatory Officer
3
SEC EDGARCymaBay Therapeutics (United States) shares after the filing of Mar 22, 2024
4
SEC EDGARForm 4 filed Jan 26, 2024